ARX Promotes Digital Signatures at China’s SFDA Conference

Dr. Gadi Aharoni, CEO of digital signature solutions provider, ARX, will join other life science industry leaders for a week long training session for the Chinese State Food and Drug Administration (SFDA) and other stakeholders in the growing Chinese pharmaceutical supply marketplace. The event will be held December 15-19, 2007 in Hainan, China.

The event focuses on Good Clinical Practice (GCP) compliance and related GxP topics such as good documentation best practices, preparation for regulatory audits, and current technology trends particularly in the clinical trial space.  Dr. Aharoni will discuss the best practice of using digital signatures (standard  electronic signatures) within an enterprise or even cross enterprise-wide strategy for regulatory compliance and other tangible business benefits such as expedited processes, reduced operational costs, and the added value of “going green” with paperless operations.

The timing of this event follows a year marked by well-publicized food and drug safety concerns that have damaged China’s credibility on the international stage. In the past year the Chinese SFDA has revoked licenses of several drug manufacturers since last July, and also withdrawn the Good Manufacturing Practice (GMP) certificates from over 100 drug makers greatly reducing their capability to export active pharmaceutical ingredients (APIs) to the rest of the world. This past summer Zheng Xiaoyu, former director of SFDA, was sentenced to death by a Beijing court citing dereliction of duty as one of numerous charges against him.

The SFDA is now expanding the number of GMP inspectors in pharmaceutical factories and monitoring the production quality of drug manufacturers across the country. The SFDA Training event is another step towards educating the Chinese food and pharmaceutical market on the best practices and technology trends – such as the use of digital signatures - in other parts of the world.

The sponsors for this event include many recognized industry thought leaders with expertise in GxP and related technology strategies. Dr. Aharoni was recognized in 2006 as one of the Top 100 Influencers by readers of PharmaVoice, and ARX is recognized as a leading digital signature solutions provider within the life sciences sector.

CoSign® is ARX's digital signature solution that allows users to digitally sign multiple document types, records, files, forms, and electronic transactions from their desktop or via a zero-footprint technology using any Web browser. By using standard digital signature technology, CoSign produces a portable signature record for every signature it captures. The portable signature format – CoSign®PSF™ enables partners, customers, and prospects to retain and verify the proof of identity, intent, and transaction integrity over the life of the record without any proprietary software. CoSign signatures are being used by hundreds of thousands of users in Enterprise, B2B and B2C processes, to learn why please see our white papers and product details at www.arx.com/products/cosign_moreinfo.php

About The Digital Signature Company - ARX (Algorithmic Research)

ARX is a global provider of digital signature solutions for the life sciences, healthcare, government, engineering, and manufacturing organizations. ARX has over 20 years of experience assistinglife sciences, healthcare, governmental, engineering, and manufacturing businesses cost effectively to secure, streamline, and scale their business processes and transactions. The company specializes in enabling organizations of any size to scale digital signature and security solutions at the lowest TCO while retaining proper control mechanisms that are required by legislation, regulation and industry best practice. For more information, please visit www.arx.com

###

CoSign is a registered trademark and CoSign PSF is a trademark of Algorithmic Research, Ltd. All other trade names and trademarks are the property of their respective holders.